Literature DB >> 9500639

Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia.

W Qunibi1, O Al-Furayh, K Almeshari, S F Lin, R Sun, L Heston, D Ross, M Rigsby, G Miller.   

Abstract

BACKGROUND: This study investigates the association between human herpesvirus eight (HHV8) and Kaposi's sarcoma (KS), the most common cancer occurring in renal transplant recipients in Saudi Arabia.
METHODS: A cross-sectional study of seroreactivity to HHV8 antigens in posttransplant KS patients from a tertiary care hospital in Riyadh, Saudi Arabia, and in control subjects without KS was conducted. Seroreactivity rates were determined using immunoblotting assays to detect antibodies to two lytic cycle HHV8 antigens: p40, an antigen found in infected cells, and sVCA, an HHV8-encoded small viral capsid antigen expressed in Escherichia coli.
RESULTS: Antibodies to HHV8 p40 and sVCA were present in a significantly higher proportion of renal transplant patients with KS (13 of 14 patients) compared to renal transplant patients without KS (5 of 18; P<0.001) and compared to other control individuals (6 of 44; P<0.001). HHV8 seroreactivity was more common among patients with renal failure (28%) than among other control groups (7%).
CONCLUSIONS: The serologic results provide evidence of a strong association between HHV8 and posttransplant KS in Saudi Arabia.

Entities:  

Keywords:  Arab Countries; Asia; Biology; Cancer; Comparative Studies; Developing Countries; Diseases; Immunity; Immunologic Factors; Neoplasms; Physiology; Renal Effects; Research Methodology; Research Report; Risk Factors; Saudi Arabia; Studies; Urogenital Effects; Urogenital System; Viral Diseases; Western Asia

Mesh:

Substances:

Year:  1998        PMID: 9500639     DOI: 10.1097/00007890-199802270-00024

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

1.  Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients.

Authors:  P Cattani; M Capuano; R Graffeo; R Ricci; F Cerimele; D Cerimele; G Nanni; G Fadda
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  Malignancy after renal transplantation: the role of immunosuppression.

Authors:  Inés Rama; Josep M Grinyó
Journal:  Nat Rev Nephrol       Date:  2010-09       Impact factor: 28.314

Review 3.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

4.  Trends in Kaposi's Sarcoma Morbidity: A Retrospective Cohort Study of Heart and Lung Transplant Recipients.

Authors:  Tal Serlin; Tuvia Ben Gal; Mordechai R. Kramer; Diana Sorin; Emmilia Hodak; Batya Davidovici
Journal:  Acta Derm Venereol       Date:  2021-08-25       Impact factor: 3.875

5.  Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency.

Authors:  Qingmei Jia; Michael L Freeman; Eric J Yager; Ian McHardy; Leming Tong; DeeAnn Martinez-Guzman; Tammy Rickabaugh; Seungmin Hwang; Marcia A Blackman; Ren Sun; Ting-Ting Wu
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

Review 6.  Avoiding pitfalls: what an endoscopist should know in liver transplantation--part II.

Authors:  Sharad Sharma; Ahmet Gurakar; Cemalettin Camci; Nicolas Jabbour
Journal:  Dig Dis Sci       Date:  2008-12-17       Impact factor: 3.199

Review 7.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

8.  Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Corey Casper; Elizabeth M Krantz; Lawrence Corey; Steven R Kuntz; Jie Wang; Stacy Selke; Shannon Hamilton; Meei-Li Huang; Anna Wald
Journal:  J Infect Dis       Date:  2008-07-01       Impact factor: 5.226

9.  Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran.

Authors:  Somayeh Jalilvand; Zabihollah Shoja; Talat Mokhtari-Azad; Rakhshandeh Nategh; Ahmad Gharehbaghian
Journal:  Infect Agent Cancer       Date:  2011-04-28       Impact factor: 2.965

10.  K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis.

Authors:  Jinshun Zhao; Vasu Punj; Hittu Matta; Lucia Mazzacurati; Sandra Schamus; Yanqiang Yang; Tianbing Yang; Yan Hong; Preethello M Chaudhary
Journal:  PLoS One       Date:  2007-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.